SSPCC is equally confident working with major pharmas as with start-up biotech and academic ventures.

We provide the following services to our clients:

• Recommendation of package of preclinical studies needed for new drug applications through to Phase IV regulatory requests
• Development of Safety Assessment Package, as independent 3rd party consultant to provide unbiased selection of appropriate studies, design, and cost analysis
• Liaison and project management of CROs, pulling together all the individual studies to centralize, oversee, and streamline the process
• Coordination and management of documentation for New Drug Applications (NDA) and Investigational New Drugs (IND)
• Liaison for academic institutions and pharmaceutical companies
• Independent 3rd party review of Good Laboratory Practices (GLP)
• Lab planning and budgeting
• Coaching of new recruits from academia to better transition them to the differing demands of the pharmaceutical industry and regulatory requirements
• Streamlined processes and procedures
• Staffing help during cyclical periods of overload

SSPCC is poised to help you secure corporate funding, venture and private equity in addition to the following services:

• Facilitating corporate partnering between companies
• Identifying and in-licensing/out-licensing technologies and products
• Developing and implementing business plans
• Providing interim business development management for early stage companies
• Assessing technologies, intellectual property, products and providing valuations
• Access to capital
• Developing and implementing product development plans to support licensing approval